Intellia Therapeutics
NTLA
NTLA
283 hedge funds and large institutions have $2.51B invested in Intellia Therapeutics in 2024 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 116 increasing their positions, 88 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
283
Holders Change
-8
Holders Change %
-2.75%
% of All Funds
4.1%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
37
Increased
116
Reduced
88
Closed
41
Calls
$21.7M
Puts
$23M
Net Calls
-$1.3M
Net Calls Change
+$7.8M
Top Buyers
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$67.3M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$15.3M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$13.6M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$11.6M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$11.4M |
